A Study of Nonoxynol-9 (N-9) and HIV Infection

NCT00000926 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4400

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nonoxynol-9

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)